Dasatinib 20 MG Oral Tablet — RxCUI 643105
RxNorm drug concept · Semantic clinical drug
RxCUI 643105
Semantic clinical drug · SCD
● Current RxNorm concept 96 FDA products
102 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI643105
Official nameDasatinib 20 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped96
Package NDCs mapped102
Reported Medicaid activity (SDUD)11,700 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dasatinib: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Your leukemia is driven by an abnormal protein called BCR-ABL, which is produced because of a chromosomal change called the Philadelphia chromosome. Think of BCR-ABL as a switch st...
- What exactly is dasatinib treating in my body?
- You can take dasatinib with or without a meal — that flexibility is built in. Just pick a consistent time of day, morning or evening, and stick with it. The one thing to avoid is g...
- Does it matter whether I take this with food or on an empty stomach?
🕸️ Concept Web — How Dasatinib 20 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dasatinib 20 MG Oral Tablet
RxCUI 643105 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Dasatinib
475342IN
-
Dasatinib
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Phyrago
2691832BN -
Sprycel
643170BN
-
Phyrago
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dasatinib Oral Tablet
643104SCDF -
Dasatinib Oral Product
1157186SCDG -
Dasatinib Pill
1157187SCDG -
Dasatinib Oral Tablet [Phyrago]
2691836SBDF -
Dasatinib Oral Tablet [Sprycel]
643172SBDF -
Phyrago Oral Product
2691834SBDG -
Phyrago Pill
2691835SBDG -
Sprycel Oral Product
1177781SBDG - +4 more in this family
-
Dasatinib Oral Tablet
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dasatinib 20 MG
643103SCDC -
Dasatinib 20 MG Oral Tablet [Phyrago]
2691841SBD -
Dasatinib 20 MG Oral Tablet [Sprycel]
643173SBD -
Dasatinib 20 MG [Phyrago]
2691840SBDC -
Dasatinib 20 MG [Sprycel]
643171SBDC
-
Dasatinib 20 MG
Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dasatinib 20 MG
SCDC · 643103 -
Dasatinib Oral Tablet
SCDF · 643104 -
Dasatinib Oral Product
SCDG · 1157186 -
Dasatinib Pill
SCDG · 1157187
Brand-Name Concepts
-
Dasatinib 20 MG Oral Tablet [Phyrago]
SBD · 2691841 -
Dasatinib 20 MG Oral Tablet [Sprycel]
SBD · 643173 -
Dasatinib 20 MG [Phyrago]
SBDC · 2691840 -
Dasatinib 20 MG [Sprycel]
SBDC · 643171 -
Dasatinib Oral Tablet [Phyrago]
SBDF · 2691836 -
Dasatinib Oral Tablet [Sprycel]
SBDF · 643172 -
Phyrago Oral Product
SBDG · 2691834 -
Phyrago Pill
SBDG · 2691835 -
Sprycel Oral Product
SBDG · 1177781 -
Sprycel Pill
SBDG · 1177782
📦 FDA Products & Package NDCs
96 products · 102 package NDCs
102 package NDCs map to RxCUI 643105 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00003-0524-11 | 1 BOTTLE in 1 CARTON (0003-0524-11) / 60 TABLET in 1 BOTTLE | SPRYCEL | E.R. Squibb & Sons, L.L.C. | 2006-06-27 |
| 00003-0527-11 | 1 BOTTLE in 1 CARTON (0003-0527-11) / 60 TABLET in 1 BOTTLE | SPRYCEL | E.R. Squibb & Sons, L.L.C. | 2006-06-27 |
| 00003-0528-11 | 1 BOTTLE in 1 CARTON (0003-0528-11) / 60 TABLET in 1 BOTTLE | SPRYCEL | E.R. Squibb & Sons, L.L.C. | 2006-06-27 |
| 00003-0852-22 | 1 BOTTLE in 1 CARTON (0003-0852-22) / 30 TABLET in 1 BOTTLE | SPRYCEL | E.R. Squibb & Sons, L.L.C. | 2008-05-30 |
| 00003-0855-22 | 1 BOTTLE in 1 CARTON (0003-0855-22) / 30 TABLET in 1 BOTTLE | SPRYCEL | E.R. Squibb & Sons, L.L.C. | 2010-10-28 |
| 00003-0857-22 | 1 BOTTLE in 1 CARTON (0003-0857-22) / 30 TABLET in 1 BOTTLE | SPRYCEL | E.R. Squibb & Sons, L.L.C. | 2010-10-28 |
| 00480-3523-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-3523-56) | Dasatinib | Teva Pharmaceuticals, Inc. | 2025-09-18 |
| 00480-3524-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-3524-56) | Dasatinib | Teva Pharmaceuticals, Inc. | 2025-09-18 |
| 00480-5101-06 | 60 TABLET, FILM COATED in 1 BOTTLE (0480-5101-06) | Dasatinib | Teva Pharmaceuticals, Inc. | 2025-09-18 |
| 00480-5102-06 | 60 TABLET, FILM COATED in 1 BOTTLE (0480-5102-06) | Dasatinib | Teva Pharmaceuticals, Inc. | 2025-09-18 |
| 00480-5103-06 | 60 TABLET, FILM COATED in 1 BOTTLE (0480-5103-06) | Dasatinib | Teva Pharmaceuticals, Inc. | 2025-09-18 |
| 00480-5104-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0480-5104-56) | Dasatinib | Teva Pharmaceuticals, Inc. | 2025-09-18 |
| 43598-0599-60 | 60 TABLET, FILM COATED in 1 BOTTLE (43598-599-60) | Dasatinib | Dr.Reddys Laboratories Inc | 2025-03-03 |
| 43598-0600-60 | 60 TABLET, FILM COATED in 1 BOTTLE (43598-600-60) | Dasatinib | Dr.Reddys Laboratories Inc | 2025-03-03 |
| 43598-0601-60 | 60 TABLET, FILM COATED in 1 BOTTLE (43598-601-60) | Dasatinib | Dr.Reddys Laboratories Inc | 2025-03-03 |
| 43598-0602-30 | 30 TABLET, FILM COATED in 1 BOTTLE (43598-602-30) | Dasatinib | Dr.Reddys Laboratories Inc | 2025-03-03 |
| 43598-0603-30 | 30 TABLET, FILM COATED in 1 BOTTLE (43598-603-30) | Dasatinib | Dr.Reddys Laboratories Inc | 2025-03-03 |
| 43598-0604-30 | 30 TABLET, FILM COATED in 1 BOTTLE (43598-604-30) | Dasatinib | Dr.Reddys Laboratories Inc | 2025-03-03 |
| 46708-0684-60 | 60 TABLET, FILM COATED in 1 BOTTLE (46708-684-60) | DASATINIB | Alembic Pharmaceuticals Limited | 2025-11-11 |
| 46708-0685-60 | 60 TABLET, FILM COATED in 1 BOTTLE (46708-685-60) | DASATINIB | Alembic Pharmaceuticals Limited | 2025-11-11 |
| 46708-0686-60 | 60 TABLET, FILM COATED in 1 BOTTLE (46708-686-60) | DASATINIB | Alembic Pharmaceuticals Limited | 2025-11-11 |
| 46708-0687-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-687-30) | DASATINIB | Alembic Pharmaceuticals Limited | 2025-11-11 |
| 46708-0688-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-688-30) | DASATINIB | Alembic Pharmaceuticals Limited | 2025-11-11 |
| 46708-0689-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-689-30) | DASATINIB | Alembic Pharmaceuticals Limited | 2025-11-11 |
| 59651-0542-15 | 1 BLISTER PACK in 1 CARTON (59651-542-15) / 15 TABLET in 1... | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 59651-0542-60 | 60 TABLET in 1 BOTTLE (59651-542-60) | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 59651-0543-15 | 1 BLISTER PACK in 1 CARTON (59651-543-15) / 15 TABLET in 1... | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 59651-0543-60 | 60 TABLET in 1 BOTTLE (59651-543-60) | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 59651-0544-15 | 1 BLISTER PACK in 1 CARTON (59651-544-15) / 15 TABLET in 1... | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 59651-0544-60 | 60 TABLET in 1 BOTTLE (59651-544-60) | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 59651-0545-15 | 1 BLISTER PACK in 1 CARTON (59651-545-15) / 15 TABLET in 1... | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 59651-0545-30 | 30 TABLET in 1 BOTTLE (59651-545-30) | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 59651-0546-15 | 1 BLISTER PACK in 1 CARTON (59651-546-15) / 15 TABLET in 1... | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 59651-0546-30 | 30 TABLET in 1 BOTTLE (59651-546-30) | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 59651-0547-15 | 1 BLISTER PACK in 1 CARTON (59651-547-15) / 15 TABLET in 1... | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 59651-0547-30 | 30 TABLET in 1 BOTTLE (59651-547-30) | DASATINIB | Aurobindo Pharma Limited | 2025-04-22 |
| 60505-3628-06 | 60 TABLET, FILM COATED in 1 BOTTLE (60505-3628-6) | Dasatinib | Apotex Corp. | 2024-09-03 |
| 60505-3629-06 | 60 TABLET, FILM COATED in 1 BOTTLE (60505-3629-6) | Dasatinib | Apotex Corp. | 2024-09-03 |
| 60505-3630-06 | 60 TABLET, FILM COATED in 1 BOTTLE (60505-3630-6) | Dasatinib | Apotex Corp. | 2024-09-03 |
| 60505-3631-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3631-3) | Dasatinib | Apotex Corp. | 2024-09-03 |
| 60505-3816-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3816-3) | Dasatinib | Apotex Corp. | 2024-09-03 |
| 60505-3817-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3817-3) | Dasatinib | Apotex Corp. | 2024-09-03 |
| 62332-0684-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62332-684-60) | DASATINIB | Alembic Pharmaceuticals Inc. | 2025-11-11 |
| 62332-0685-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62332-685-60) | DASATINIB | Alembic Pharmaceuticals Inc. | 2025-11-11 |
| 62332-0686-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62332-686-60) | DASATINIB | Alembic Pharmaceuticals Inc. | 2025-11-11 |
| 62332-0687-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-687-30) | DASATINIB | Alembic Pharmaceuticals Inc. | 2025-11-11 |
| 62332-0688-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-688-30) | DASATINIB | Alembic Pharmaceuticals Inc. | 2025-11-11 |
| 62332-0689-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-689-30) | DASATINIB | Alembic Pharmaceuticals Inc. | 2025-11-11 |
| 66993-0233-60 | 1 BOTTLE in 1 CARTON (66993-233-60) / 60 TABLET in 1 BOTTLE | Dasatinib | Prasco Laboratories | 2024-09-03 |
| 66993-0234-60 | 1 BOTTLE in 1 CARTON (66993-234-60) / 60 TABLET in 1 BOTTLE | Dasatinib | Prasco Laboratories | 2024-09-03 |
Observed labelers:
Aurobindo Pharma Limited (12) ·
Alembic Pharmaceuticals Inc. (6) ·
Alembic Pharmaceuticals Limited (6) ·
Apotex Corp. (6) ·
AvKARE (6) ·
Biocon Pharma Inc. (6)
· +10 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.